Blogs
Zuora’s CFO to Participate at the Goldman Sachs 2023 Communacopia + Technology Conference
REDWOOD CITY, Calif.--(ZEEST MEDIA)--Zuora (NYSE: ZUO), a leading monetization suite for modern businesses, today announced that its Chief Financial Officer, Todd McElhatton, will participate in a fireside chat at the Goldman Sachs 2023 Communacopia + Technology...
i2o Therapeutics Names Kurt Graves Chairman and CEO, Announces Corporate Updates
BOSTON--(ZEEST MEDIA)--i2o Therapeutics, Inc. today announced the appointment of Kurt Graves as Chairman, President and CEO. He was previously Executive Chairman of the Board, a position he held since August 2021. Mr. Graves succeeds i2o co-founder and CEO Ravi...
Bragg Gaming Group Appoints Matevž Mazij CEO
TORONTO--(ZEEST MEDIA)--Bragg Gaming Group Inc. (NASDAQ: BRAG, TSX: BRAG) (“Bragg” or the “Company”), a global B2B gaming technology and content provider, today announced the Board of Directors (the “Board”) has appointed Matevž Mazij, Chairman of the Board, as Chief...
Jack Nathan Health Announces Appointment of Permanent Chief Financial Officer, Mr. Bharat Choudhary
TORONTO--(ZEEST MEDIA)--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health” or the “Company”) is pleased to announce the appointment of Mr. Bharat Choudhary as the Company’s new permanent Chief Financial Officer (CFO). The Company's board of...
Global PC Shipments Expected to Return to Growth in 2024 Albeit Below 2019 Pre-Pandemic Levels, According to IDC
NEEDHAM, Mass.--(ZEEST MEDIA)--The road to recovery for personal computers (PCs) has been challenging coming off explosive years in 2020 and 2021, but signs of growth are finally returning. According to the International Data Corporation (IDC) Worldwide Quarterly...
Overseas Shipholding Group Announces Off-Market Share Repurchase
TAMPA, Fla.--ZEEST MEDIA)--Overseas Shipholding Group, Inc. (NYSE: OSG) (the “Company” or “OSG”) today announced that it has agreed to purchase 3,788,639 shares of the Company’s common stock from entities managed by Cyrus Capital Partners, L.P. at a price of $4.05 per...
AMTD IDEA Group announced a step up of approx. US$100million into AMTD Digital Inc. with a lock up of 5 years
NEW YORK & PARIS--ZEEST MEDIA)--AMTD Digital Inc. (“AMTD Digital”, NYSE: HKD) AMTD IDEA Group (“AMTD IDEA”, NYSE: AMTD; SGX: HKB) jointly announced today that the boards of directors of the two companies have approved the issuance and sale of Class B ordinary...
WWE® & NFL Announce First-Ever Officially Licensed NFL Legacy Title Belts
STAMFORD, Conn.--(ZEEST MEDIA)--The National Football League and WWE® (NYSE: WWE) today announced a multi-year licensing deal to create NFL-inspired WWE legacy title belts featuring the official colors and branding of all 32 teams. “Management's Discussion and...
Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers
SAN FRANCISCO--(ZEEST MEDIA)--Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that the Company has entered into a non-exclusive agreement with...
Enveric Biosciences Strengthens Intellectual Property Portfolio with New U.S. Patent for Tryptamine-derived Prodrugs
CAMBRIDGE, Mass.--(ZEEST MEDIA--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, and addiction...
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors
LOS ANGELES--(ZEEST MEDIA)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) common stock...
Long-Term Follow-Up Data from Two Phase 3 Studies of CAMZYOS® (mavacamten) Demonstrate Consistent and Durable Response in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM
PRINCETON, N.J.--(ZEEST MEDIA)--Bristol Myers Squibb (NYSE: BMY) today announced new long-term follow-up results from two Phase 3 studies evaluating CAMZYOS® (mavacamten), a first-in-class cardiac myosin inhibitor, in adult patients with symptomatic obstructive...